Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis (Q30479961)

1 November 2017

9 references

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

11 September 2020

28 January 2021

6 February 2021

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis (English)

1 reference

1 November 2017

8 references

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

11 September 2020

28 January 2021

8 references

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

29 May 2020

11 September 2020

9 references

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

11 September 2020

28 January 2021

6 February 2021

1 reference

18 November 2019

1 reference

11 September 2020

1 reference

6 February 2021

4

1 reference

1 November 2017

Andrew Prayle

1

1 reference

1 November 2017

Alan Watson

series ordinal

2

1 reference

1 November 2017

Heather Fortnum

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 July 2010

11 references

1 November 2017

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

29 May 2020

11 September 2020

28 January 2021

6 February 2021

11 references

1 November 2017

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

29 May 2020

11 September 2020

28 January 2021

6 February 2021

65

1 reference

1 November 2017

654-658

1 reference

1 November 2017

7

1 reference

Creative Commons Attribution-NonCommercial

1 November 2017

9 references

13 March 2019

21 March 2019

22 April 2019

25 April 2019

22 June 2019

18 November 2019

11 September 2020

28 January 2021

6 February 2021

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Survey of acute renal failure in patients with cystic fibrosis in the UK.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Aspirin to prevent gentamicin-induced hearing loss

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Identification of putative gene based markers of renal toxicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: A Case Presentation and Review of the Literature.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Effects of gentamicin and pH on [Ca2+]i in apical and basal outer hair cells from guinea pigs.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Aminoglycosides: nephrotoxicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Ultrastructural localization of megalin in the rat cochlear duct

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Renal ultrastructural and biochemical injuries induced by aminoglycosides

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Randomized trials of aminoglycoside antibiotics: quantitative overview

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Kinetics of gentamicin in cochlear hair cells after chronic treatment.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Accumulation pharmacokinetics of tobramycin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Tobramycin ototoxicity. Repeated courses of high dosage treatment in children with cystic fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Cystic Fibrosis and Hearing Loss

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Prevalence of mitochondrial 1555A-->G mutation in adults of European descent.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Frequency of mitochondrial 12S ribosomal RNA variants in an adult cystic fibrosis population

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Case-control study of acute renal failure in patients with cystic fibrosis in the UK.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Aminoglycosides inhibit hormone-stimulated Mg2+ uptake in mouse distal convoluted tubule cells

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Effects of chronic tobramycin treatment on distortion product otoacoustic emissions

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Aminoglycosides lower serum magnesium concentrations in patients with cystic fibrosis: a retrospective study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2921289

Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis

26 November 2018

1 reference

12 December 2020

Prevalence of Mitochondrial 1555A→G Mutation in European Children

1 reference

12 December 2020

Supplemental iron exacerbates aminoglycoside ototoxicity in vivo

1 reference

12 December 2020

Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity

1 reference

12 December 2020

Aminoglycoside ototoxicity

1 reference

12 December 2020

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.2009.131532

1 reference

1 November 2017

1 reference

1 November 2017

1 reference